2020
DOI: 10.1002/ccr3.3258
|View full text |Cite
|
Sign up to set email alerts
|

Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report

Abstract: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Rituximab is an approved treatment for both RA and GPA so intuitively seems to be a good choice for the overlap condition. There are published case reports of the effective use of rituximab for the treatment of patients with coexisting GPA and RA [ 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Rituximab is an approved treatment for both RA and GPA so intuitively seems to be a good choice for the overlap condition. There are published case reports of the effective use of rituximab for the treatment of patients with coexisting GPA and RA [ 23 ].…”
Section: Discussionmentioning
confidence: 99%